The Office of the Chief Scientist (OCS) in Israel has awarded $3m NIS grant to support BrainStorm Cell Therapeutics' research and development program for stem cell therapy candidate, NurOwn. NurOwn is an autologous, adult stem cell ...
Tags: stem cell therapy technology, Cell Therapeutics, therapy technology